Fund Holdings — Caligan Partners LP

Total Portfolio Value:
$428.00M
Total Bought:
$63.89M
Total Sold:
$2.52M
Net Transaction:
+$61.37M
Notable People:
Caligan Partners Gp Llc
Securities
▲▼
SharesValue
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Liquidia Corporation(LQDA)10,360,94510,360,9450$152.82M$124.33M29.05%-$28.49M
Alimera Sciences Inc16,835,15416,835,1540$65.66M$93.60M21.87%+$27.95M
Anika Therapeutics Inc1,435,9931,435,9930$36.47M$36.37M8.50%-$100.5K
Exelixis, Inc.(EXEL)1,100,7301,525,730+425,000$26.12M$34.28M8.01%+$8.16M
BioCryst Pharmaceuticals, Inc.(BCRX)758,5024,598,737+3,840,235$3.85M$28.42M6.64%+$24.57M
Verona Pharma PlcADS1,296,4471,843,756+547,309$20.86M$26.66M6.23%+$5.80M
Evolus, Inc.(EOLS)1,888,8812,167,790+278,909$26.44M$23.52M5.50%-$2.92M
Agios Pharmaceuticals, Inc.(AGIO)484,711514,711+30,000$14.17M$22.19M5.19%+$8.02M
Enanta Pharmaceuticals, Inc.(ENTA)858,0701,042,889+184,819$14.98M$13.53M3.16%-$1.46M
Mineralys Therapeutics, Inc.(MLYS)0745,758+745,758$0$8.73M2.04%+$8.73M
Y-Mabs Therapeutics Inc587,276582,078-5,198$9.55M$7.03M1.64%-$2.52M
NovaBridge BiosciencesADS(NBP)756,5383,374,791+2,618,253$1.41M$5.64M1.32%+$4.23M
Outlook Therapeutics, Inc.(OTLK)500,000500,0000$5.97M$3.69M0.86%-$2.28M
Page 1 of 1
Caligan Partners LP — 13F Holdings — Q2 2024 | TickerTrail